Papers by Timo Grimmer · AgingResearch.News

Medical Image Analysis4 Oct
Cortex-grounded diffusion models for brain image generation
Computational studyAI & data
Paper
arXiv17 Sep
Bridging Modalities on the Cortex: Surface-based MRI to PET Translation with a Diffusion Bridge
Preprint: computational studyAI & data
Paper
CNS Drugs15 Sep
From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease
ReviewInterventions
Paper
Nature Genetics15 Sep
APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers's disease
Study in peopleMechanisms
Paper

AAIC 2025 Abstract26 Dec
Precision Medicine in Alzheimer’s Disease (AD): Observed Efficacy Treatment Effects from Blarcamesine Clinical AD Trials
Trial in peopleInterventions
Paper
AAIC 2025 Abstract26 Dec
A Patient‐Centric, Digital Multimodal Post‐Market Approval Continuous Monitoring of Drug Safety & Efficacy Platform for Blarcamesine
AI & data
Paper
AAIC 2025 Abstract26 Dec
Phase IIb/III ATTENTION‐AD Study: Over Three Years of Continuous Treatment with Oral Blarcamesine Continues to Significantly Benefit Early Alzheimer’s Disease Patients
Trial in peopleInterventions
Paper
AAIC 2025 Abstract26 Dec
The 3‐item short version of the Bayer‐ADL scale as a screening tool for distinguishing mild cognitive impairment from dementia in primary care
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract24 Dec
Microglial Activation and Tau Accumulation in the Alzheimer's Disease Spectrum: Insights from Longitudinal PET Imaging
Study in peopleMechanisms
Paper